Request Deal Involvement
Carlyle and GTCR-backed Resonetics to acquire medical nitinol business from SAES for $900m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Mediobanca
or
Principals
bidder
RESONETICS
target
SAES (MEDICAL NITINOL BUSINESS)
vendor
SAES GETTERS SPA
bidder
THE CARLYLE GROUP
bidder
GTCR LLC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite